← Back to Search

Multisystemic Therapy for Emerging Adults for Substance Abuse

N/A

Waitlist Available

Led By Ashli J Sheidow, Ph.D.

Research Sponsored by Oregon Social Learning Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 16 months pre-baseline compared with 16 months post-baseline.

Awards & highlights

Study Summary

This trial is testing a new intervention for young adults who abuse drugs and alcohol and have been in trouble with the law, to see if it can help reduce criminal activity.

Who is the study for?

This trial is for young adults aged 16-26 with a history of alcohol or drug abuse and recent justice involvement, who are not currently homeless or in-patient. They must have had an arrest or release from custody within the last 18 months and show signs of substance abuse disorder.Check my eligibility

What is being tested?

The study tests Multisystemic Therapy-Emerging Adults (MST-EA) against Enhanced Treatment as Usual to see if it reduces criminal activity, substance use, improves gainful activities like work and education, stabilizes housing, decreases antisocial behavior, and enhances self-regulation among emerging adults.See study design

What are the potential side effects?

Since MST-EA is a behavioral therapy intervention rather than a medication, it does not have traditional side effects. However, participants may experience emotional discomfort addressing personal issues during therapy sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 16 months pre-baseline compared with 16 months post-baseline.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~16 months pre-baseline compared with 16 months post-baseline.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 months pre-baseline compared with 16 months post-baseline. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in number and severity of criminal charges in official records in the 16 months pre-Baseline compared with the 16 months post-Baseline.

Changes from Baseline scores compared to 16 months post-Baseline Offending Behaviors (measured at 0, 2, 4, 6, 8, 12 and 16 months).

Secondary outcome measures

Changes from Baseline scores compared to 16 months post-Baseline Antisocial Peers Involvement (measured at 0, 2, 4, 6, 8, 12 and 16 months).

Changes from Baseline scores compared to 16 months post-Baseline Goal Directedness (measured at 0, 2, 4, 6, 8, 12 and 16 months).

Changes from Baseline scores compared to 16 months post-Baseline Housing Stability (measured at 0, 2, 4, 6, 8, 12 and 16 months).

+9 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Multisystemic Therapy-Emerging AdultsExperimental Treatment1 Intervention

This group will receive Multisystemic Therapy-Emerging Adults.

Group II: Enhanced Treatment as UsualActive Control1 Intervention

This group will have access to an enhanced version of services typically delivered to young adults who have a substance use disorder and have been in trouble with the law.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Youth VillagesOTHER

2 Previous Clinical Trials

247 Total Patients Enrolled

1 Trials studying Antisocial Personality Disorder

193 Patients Enrolled for Antisocial Personality Disorder

Chestnut Health SystemsOTHER

20 Previous Clinical Trials

23,102 Total Patients Enrolled

Oregon Social Learning CenterLead Sponsor

35 Previous Clinical Trials

10,592 Total Patients Enrolled

1 Trials studying Antisocial Personality Disorder

193 Patients Enrolled for Antisocial Personality Disorder

Media Library

Multisystemic Therapy-Emerging Adults Clinical Trial Eligibility Overview. Trial Name: NCT03035877 — N/A

Antisocial Personality Disorder Clinical Trial 2023: Multisystemic Therapy-Emerging Adults Highlights & Side Effects. Trial Name: NCT03035877 — N/A

Multisystemic Therapy-Emerging Adults 2023 Treatment Timeline for Medical Study. Trial Name: NCT03035877 — N/A

Antisocial Personality Disorder Research Study Groups: Multisystemic Therapy-Emerging Adults, Enhanced Treatment as Usual

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the eligibility of this study limited to individuals younger than 35 years old?

"The criteria for inclusion stipulate that potential enrollees must be between 16 and 26 years of age."

Answered by AI

Where are the various sites conducting this clinical trial?

"Currently, 4 sites are participating in this research. These include Hamden, New Haven and Hartford as well as others. It is highly recommended that you select the closest location to reduce travel-related strain on yourself if accepted into the trial."

Answered by AI

Has enrollment for this clinical experiment opened yet?

"On clinicaltrials.gov, this medical trial has been declared inactive; the study was initially posted in August 2017 and its last update was on 24th May 2022. Despite no longer recruiting patients, there are 6 other active studies that you can consider participating in."

Answered by AI

Are there any requirements for individuals to enroll in this experiment?

"Aspiring enrollees must present with dyssocial behaviour and be between the ages of 16 and 26 to qualify for this research study, which intends on admitting a total of 191 participants."

Answered by AI

What primary goals is this trial attempting to accomplish?

"This trial's primary goal is to evaluate changes in the Offending Behaviors of participants over a 16-month time frame, by comparing pre and post Baseline scores. Secondary outcomes involve measuring Housing Stability (through Time Line Follow Back surveys and archival records), Responsibility Taking (with Behavioral Indicators of Conscientiousness questionnaires) and Interpersonal Competence (utilizing Interpersonal Competence Scale assessments)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse

Ashli Sheidow 2017. "Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03035877.

All > Substance Abuse